Nordhealth AS (OSL:NORDH)

Nordhealth AS Statistics

Total Valuation

Nordhealth AS has a market cap or net worth of NOK 2.84 billion. The enterprise value is 2.58 billion.

Market Cap	2.84B
Enterprise Value	2.58B

Important Dates

The next estimated earnings date is Tuesday, August 19, 2025.

Earnings Date	Aug 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Nordhealth AS has 78.81 million shares outstanding.

Current Share Class	43.81M
Shares Outstanding	78.81M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	51.99%
Owned by Institutions (%)	12.49%
Float	35.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	75.75
PS Ratio	5.20
PB Ratio	3.46
P/TBV Ratio	13.87
P/FCF Ratio	n/a
P/OCF Ratio	63.85
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-28.32
EV / Sales	4.73
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-206.43

Financial Position

The company has a current ratio of 2.37

Current Ratio	2.37
Quick Ratio	2.27
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-211.00

Financial Efficiency

Return on equity (ROE) is -10.64% and return on invested capital (ROIC) is -6.29%.

Return on Equity (ROE)	-10.64%
Return on Assets (ROA)	-5.36%
Return on Invested Capital (ROIC)	-6.29%
Return on Capital Employed (ROCE)	-10.51%
Revenue Per Employee	1.29M
Profits Per Employee	-215,741
Employee Count	411
Asset Turnover	0.54
Inventory Turnover	n/a

Taxes

In the past 12 months, Nordhealth AS has paid 12.06 million in taxes.

Income Tax	12.06M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.65% in the last 52 weeks. The beta is 0.44, so Nordhealth AS's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	+4.65%
50-Day Moving Average	38.02
200-Day Moving Average	38.31
Relative Strength Index (RSI)	38.57
Average Volume (20 Days)	892

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nordhealth AS had revenue of NOK 545.88 million and -91.26 million in losses. Loss per share was -1.15.

Revenue	545.88M
Gross Profit	188.53M
Operating Income	-86.37M
Pretax Income	-79.19M
Net Income	-91.26M
EBITDA	-7.83M
EBIT	-86.37M
Loss Per Share	-1.15

Balance Sheet

The company has 252.99 million in cash and n/a in debt, giving a net cash position of 252.99 million or 3.21 per share.

Cash & Cash Equivalents	252.99M
Total Debt	n/a
Net Cash	252.99M
Net Cash Per Share	3.21
Equity (Book Value)	818.96M
Book Value Per Share	10.36
Working Capital	194.66M

Cash Flow

In the last 12 months, operating cash flow was 44.44 million and capital expenditures -56.95 million, giving a free cash flow of -12.52 million.

Operating Cash Flow	44.44M
Capital Expenditures	-56.95M
Free Cash Flow	-12.52M
FCF Per Share	-0.16

Margins

Gross margin is 34.54%, with operating and profit margins of -15.82% and -16.72%.

Gross Margin	34.54%
Operating Margin	-15.82%
Pretax Margin	-14.51%
Profit Margin	-16.72%
EBITDA Margin	-1.44%
EBIT Margin	-15.82%
FCF Margin	n/a

Dividends & Yields

Nordhealth AS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-3.22%
FCF Yield	-0.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4